Erratum: Emergency admission for cancer - a matter of survival? (British Journal of Cancer, (1998), 77, 3, (353-358), 10.1038/bjc.1998.57);99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein

British Journal of Cancer

Volumn 77, Issue 3, 1998, Pages 353-358

  Hendrikse, N H ^a   Franssen, E J F ^a   Van Der Graaf, W T A ^a   Meijer, C ^a   Piers, D A ^a   Vaalburg, W ^a   De Vries, E G E ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

99mTc sestamibi; Drug transport; Multidrug resistance; Multidrug resistance associated protein; P glycoprotein

Indexed keywords

ANTIBIOTIC G 418; DOXORUBICIN; GLUTATHIONE; GLYCOPROTEIN P; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MULTIDRUG RESISTANCE PROTEIN; VERAPAMIL; VINCRISTINE; ABC TRANSPORTER;

ARTICLE; CANCER CELL CULTURE; DRUG CYTOTOXICITY; GAMMA RADIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; CELL CULTURE; CELL SURVIVAL; METABOLISM; MULTIDRUG RESISTANCE; PHYSIOLOGY; RADIATION EXPOSURE;

ATP-BINDING CASSETTE TRANSPORTERS; CELL SURVIVAL; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; GLUTATHIONE; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; TECHNETIUM TC 99M SESTAMIBI; TUMOR CELLS, CULTURED;

EID: 0031594608     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1998.285     Document Type: Erratum

References (32)

1. 99mTc-sestamibi as an agent for imaging P-glycoprotein-mediated multidrug resistance: in vitro and in vivo studies in a rat breast tumour cell line and its doxorubicin-resistant variant. Nucl Med Comm 16: 253-257
2. Bradley G, Juranka PF and Ling V (1988) Mechanism of multidrug resistance. Biochem Biophys Acta 948: 87-128
3. Brock I, Hipfner DR, Nielsen BS, Jensen PB, Deeley RG, Cole SPC and Sehested M (1995) Sequential coexpression of the multidrug resistance genes MRP and mdr1 and their products in VP-16 (etoposide)-selected H69 small cell lung cancer cells. Cancer Res 55: 459-462
4. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan MV and Deeley RG (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650-1654
5. De Jong S, Zijlstra JG, De Vries EGE and Mulder NH (1990) Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res 50: 304-309
6. De Vries EGE, Meijer C, Timmer-Bosscha H, Berendsen HH, De Leij L, Scheper RJ and Mulder NH (1989) Resistance mechanisms in three human small cell lung cancer cell lines established from one patient during clinical follow up. Cancer Res 49: 4175-4178
7. Endicott JA and Ling V (1989) The biochemistry of P-glycoprotein-mediated multidrug resistance. Ann Rev Biochem 58: 137-171
8. Evers R, Zaman GJR, Van Deemter L, Jansen H, Calafat J, Oomen LCJM, Oude Elferink RPJ, Borst P and Schinkel AH (1996) Basolateral localization and export activity of the human multidrug resistance-associated protein (MRP) in polarized pig kidney cells. J Clin Invest 97: 1211-1218
9. Ishikawa T (1992) The ATP-dependent glutathione S-conjugate export pump. Trends Biochem Sci 17: 463-468
10. Jedlitschky G, Leier I, Bucholz U, Center M and Keppler D (1994) ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res 54: 4833-4836
11. Leier I, Jedlitschky G, Bucholz U, Cole SPC, Deeley RG and Keppler D (1994) The MRP gene encodes an ATP-dependent export pump for leukotriene c-4, and structurally related conjugates. J Biol Chem 269: 27807-27810
12. Meijer C, Mulder NH and De Vries EGE (1990) The role of detoxification systems in resistance of tumor cells to cisplatin and adriamycin. A review. Cancer Treatm Rev 17: 389-407
13. Meijer C, Mulder NH, Timmer-Bosscha H, Peters WHM and De Vries EGE (1991) Combined in-vitro modulation of adriamycin resistance. Int J Cancer 49: 582-586
14. Müller M, Meijer C, Zaman GJR, Borst P, Scheper RJ, Mulder NH, De Vries EGE and Jansen PLM (1994) Overexpression of the multidrug resistance associated protein (MRP) gene results in increased ATP-dependent glutathione S-conjugate transport. Proc Natl Acad Sci USA 91: 13033-13037
15. Pastan I and Gottesman MM (1987) Multiple-drug resistance in human cancer. N Engl J Med 316: 1388-1393
16. Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA and Croop JM (1993) Functional imaging of multidrug resistance P-glycoprotein with an organotechnetium complex. Cancer Res 53: 977-984
17. r 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res 53: 1475-1479
18. Schuurhuis GJ, Broxterman HJ, Ossenkoppele GJ, Baak JPA, Eekman CA, Kuiper CM, Feller N, Van Heijningen THM, Klumper E, Pieters R, Lankelma J and Pinedo HM (1995) Functional multidrug resistance phenotype associated with combined overexpression of Pgp/mdr1 and MRP together with 1-β-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia. Clin Cancer Res 1: 81-93
19. Simon SM and Schindler M (1994) Cell biological mechanisms of multidrug resistance in tumor. Proc Natl Acad Sci USA 91: 3497-3504
20. Steel GG and Peckman MJ (1979) Exploitable mechanisms in combined radiotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys 5: 85-91
21. Sugawara I, Kataoka I, Morishita T, Hamada H, Tsuruo T, Itoyama S and Mori S (1988) Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK16. Cancer Res 48: 1926-1929
22. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I and Wilingham MC (1987) Cellular localization of the multidrug resistance gene product in normal human tissues. Proc Natl Acad Sci USA 84: 7735-7738
23. Timmer-Bosscha H, Hospers GAP, Meijer C, Mulder NH, Muskiet FAJ, Martini DRA and De Vries EGE (1989) Influence of docosahexaenoic acid on cisplatin resistance in a human small cell lung carcinoma cell line. J Natl Cancer Inst 81: 1069-1075
24. Twentyman PR and Versantvoort CHM (1996) Experimental modulation of MRP (multidrug resistance-associated protein)-mediated resistance. Eur J Cancer 32A: 1002-1009
25. Vallabhaneni VR, Chiu ML, Kronauge JF and Piwnica-Worms D (1994) Expression of recombinant human multidrug resistance P-glycoprotein in insect cells confers decreased accumulation of technetium-99m-sestamibi. J Nucl Med 35: 510-515
26. Versantvoort CHM, Broxterman HJ, Pinedo HM, De Vries EGE, Feller N, Kuiper CM and Lankelma J (1992) Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression. Cancer Res 52: 17-23
27. 4 sublines with increasing adriamycin resistance. Int J Cancer 61: 375-380
28. Versantvoort CHM, Broxterman HJ, Bagrij T, Scheper RJ and Twentyman PR (1995b) Regulation by glutathione of drug transport in multidrug-resistant human lung tumor cell lines overexpressing multidrug resistance-associated protein. Br J Cancer 72: 82-89
29. Wishart GC, Bissett D, Paul J, Jodrell D, Harnett A, Habeshaw T, Kerr DJ, Macham MA, Soukop M, Leonard RCF, Knepil J and Kaye SB (1994). Quinidine as a resistance modulator of epirubicin in advanced breast cancer: mature results of a placebo-controlled randomized trial. J Clin Oncol 12: 1771-1777
30. Zaman GJR, Flens MJ, Van Leusden MR, De Haas M, Mülder HS, Lankelma J, Pinedo HM, Scheper RJ, Baas F, Broxterman HJ and Borst P (1994) The human multidrug resistance-associated protein (MRP) is a plasma membrane drug-efflux pump. Proc Natl Acad Sci USA 91: 8822-8826
31. Zaman GJR, Lankelma J, Van Tellingen O, Beijnen J, Dekker H, Paulusma C, Oude Elferink RPJ, Baas F and Borst P (1995) Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc Natl Acad Sci USA 92: 7690-7694
32. Zijlstra JG, De Vries EGE and Mulder NH (1987) Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res 47: 1780-1784